Uncategorized

Alto’s depression candidate bolstered by independent study showing mood benefits

Published

on

Alto Neuroscience is advancing a depression drug based on the dopamine agonist pramipexole, which an independent study has found to help boost feelings of pleasure in patients with mood disorders.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version